Standardized SEC financial data for Apyx Medical Corp — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000719135 · NASDAQ · Surgical & Medical Instruments & Apparatus.
Ratios for fiscal year 2025, standardized from SEC filings.
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $27.7M | $48.5M | $44.5M | $52.3M | $48.1M | $52.8M |
| Cost of revenue | $10.2M | $14.9M | $15.4M | $18.6M | $18.7M | $19.8M |
| Gross profit | $17.5M | $33.6M | $29.1M | $33.8M |
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $41.9M | $30.9M | $10.2M | $43.7M | $31.7M | $31.7M |
| Inventory | $4.4M | $7.0M | $12.3M | $10.8M | $8.6M | $9.8M |
| Total current assets | $66.1M | $60.7M | $43.0M | $70.4M |
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$16.1M | -$10.4M | -$20.3M | -$5.2M | -$18.0M | -$8.0M |
| Capital expenditures | $581K | $723K | $1.0M | $533K | $722K | $1.1M |
| Free cash flow | -$16.6M | -$11.2M | -$21.3M | -$5.8M |
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/APYX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/APYX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"| $29.4M |
| $33.0M |
| R&D expense | $3.9M | $4.3M | $4.5M | $5.4M | $5.1M | $3.4M |
| SG&A expense | $11.7M | $18.6M | $20.5M | $22.2M | $18.9M | $15.8M |
| Operating income | -$20.1M | -$14.4M | -$23.6M | -$17.3M | -$18.8M | -$6.4M |
| EBITDA | -$19.2M | -$13.5M | -$22.7M | -$16.6M | -$18.2M | -$5.8M |
| Interest expense | $46K | $10K | $15K | $2.5M | $4.7M | $4.6M |
| Pretax income | -$19.4M | -$14.8M | -$22.9M | -$21.3M | -$23.3M | -$10.8M |
| Income tax | $7.5M | $380K | $367K | $2.4M | $252K | $270K |
| Net income | -$11.9M | -$15.2M | -$23.2M | -$18.7M | -$23.5M | -$11.2M |
| EPS (diluted) | $-0.35 | $-0.44 | $-0.67 | $-0.54 | — | — |
Standardized from Apyx Medical Corp's SEC filings — per-share figures split-adjusted. Full history via the API.
| $56.4M |
| $58.5M |
| Property, plant & equipment | $6.5M | $6.6M | $6.8M | $1.9M | $2.0M | $2.4M |
| Total assets | $74.1M | $68.7M | $51.8M | $79.2M | $64.8M | $66.8M |
| Total current liabilities | $9.2M | $13.2M | $11.8M | $12.7M | $10.7M | $11.7M |
| Long-term debt | — | — | $0 | $33.2M | $37.5M | $37.5M |
| Total debt | — | — | $0 | $33.2M | $37.5M | $37.5M |
| Total liabilities | $10.3M | $14.7M | $14.0M | $52.3M | $50.5M | $52.0M |
| Retained earnings | $2.6M | -$12.6M | -$35.7M | -$54.4M | -$77.9M | -$89.1M |
| Total equity | $63.9M | $54.0M | $37.8M | $26.9M | $14.3M | $14.8M |
| -$18.8M |
| -$9.1M |
| Investing cash flow | -$581K | -$723K | -$1.0M | $6.7M | -$722K | -$1.1M |
| Financing cash flow | -$73K | $24K | $217K | $32.2M | $6.7M | $9.6M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 | $0 |